EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbial metabolites and the brain–gut axis in Alzheimer’s disease: A review

Xinchen Ji, Jian Wang, Tianye Lan, Dexi Zhao, Peng Xu

Biomolecules and Biomedicine · 11.08.2025 · 26 (2) · 240-250

DOI: 10.17305/bb.2025.12921 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 11.08.2025. Verfasst von Xinchen Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit wurde bisher 39-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is increasingly recognised as a disorder that extends beyond the brain, with accumulating evidence implicating gut microbiota–derived metabolites in its onset and progression. This narrative review synthesises 92 peer-reviewed animal, human and meta-analytic studies published between 2010 and 2025 that investigated short-chain fatty acids (SCFAs), tryptophan-derived indoles and kynurenines, trimethylamine N-oxide (TMAO) and secondary bile acids in the context of AD. Collectively, the literature shows that SCFAs support blood–brain-barrier integrity, dampen microglial reactivity and enhance synaptic plasticity, yet can paradoxically amplify β-amyloid (Aβ) deposition under germ-free or supraphysiological conditions, highlighting the importance of host status and dosing. Beneficial indole metabolites such as indole-3-propionic acid counter oxidative stress, strengthen intestinal and cerebral barriers and suppress pro-inflammatory cascades, whereas a shift toward neurotoxic kynurenines correlates with cognitive decline. TMAO emerges as a consistently deleterious metabolite that aggravates endothelial dysfunction, neuroinflammation and Aβ aggregation; dietary precursor restriction and microbial enzyme inhibitors are therefore being explored as mitigation strategies. Secondary bile acids and polyphenol derivatives further modulate mitochondrial bioenergetics and NF-κB signalling, broadening the therapeutic landscape. Multi-omics profiling reveals that AD patients typically exhibit reduced SCFAs and indoles but elevated TMAO, changes that scale with Mini-Mental State Examination scores, brain atrophy and cerebrospinal Aβ₄₂ levels. Early probiotic and faecal-microbiota-transplant trials have begun to normalise these metabolite profiles and yield modest cognitive benefits, underscoring translational potential. Altogether, gut-derived metabolites are not passive by-products but active modulators of neural, immune and metabolic circuits along the microbiota–gut–brain axis; their targeted manipulation and standardised metabolomic assessment could enable earlier diagnosis and precision microbiome-based interventions for AD, a promise that now warrants validation in large, longitudinal and mechanistically informed clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeBrainBrain-Gut AxisHumansAnimalsMethylaminesFatty Acids, Volatile

Substanzen

MethylaminesFatty Acids, Volatile

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • Department of Encephalopathy, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
  • Department of Rehabilitation, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.

Zitieren

APA

Ji, X., Wang, J., Lan, T., Zhao, D., & Xu, P. (2025). Gut microbial metabolites and the brain–gut axis in Alzheimer’s disease: A review. Biomolecules and Biomedicine, 26(2), 240-250. https://doi.org/10.17305/bb.2025.12921

Vancouver

Ji X, Wang J, Lan T, Zhao D, Xu P. Gut microbial metabolites and the brain–gut axis in Alzheimer’s disease: A review. Biomolecules and Biomedicine. 2025;26(2):240-250. doi:10.17305/bb.2025.12921

BibTeX
@article{Ji2025,
  author = {Ji, Xinchen and Wang, Jian and Lan, Tianye and Zhao, Dexi and Xu, Peng},
  title = {Gut microbial metabolites and the brain–gut axis in Alzheimer’s disease: A review},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  volume = {26},
  number = {2},
  pages = {240--250},
  doi = {10.17305/bb.2025.12921}
}
Kostenlos starten →